Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Low Dose Naltrexone for Vulvodynia
NCT07862400Phase 2Not yet recruiting
- Sponsor
- University of Florida
- Start
- Jan 2027
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in vulvodynia, sponsored by University of Florida. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
vulvodynia
Beyond the preview
Go deeper on NCT07862400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07862400.